Skip to main content

Featured

Canada’s Auto Industry Is Split on a U.S. Tariff Deal: What It Means for Your Wallet

  Canadian Money Brief • Tariffs & Trade • Saturday, November 14, 2026 Ottawa is once again trying to land a tariff deal with Washington. This time, the biggest fight may be inside Canada's own auto industry, and the outcome could reach your paycheque, your car purchase and your savings. Canada's auto manufacturers agree on the goal: get U.S. tariffs on Canadian-built vehicles down. They do not agree on how fast to move or what to accept. According to a Globe and Mail report published overnight, the Detroit Three (Ford, GM and Stellantis) want a deal sooner rather than later, even an imperfect one, while Honda and Toyota are pushing Ottawa toward a very different design. It matters now because of the clock. Canadian-built vehicles already face a 25% U.S. tariff on their non-American content, and Washington has threatened to double the headline rate to 50% on January 1, 2027. Honda has warned that doubling would be catastrophic for the North American industry. Prime Minister...

article

Cancer-Causing Chemical Detected in Acne Treatments: Brands Under Scrutiny

 


In a recent alarming discovery, independent U.S. laboratory Valisure has detected high levels of the cancer-causing chemical benzene in certain acne treatments. Brands affected include:

  1. Clinique (Estee Lauder)
  2. Clearasil (Reckitt Benckiser-owned)
  3. Proactiv
  4. Target Corp.'s Up & Up
  5. PanOxyl
  6. Walgreens’ acne soap bar
  7. Walmart’s Equate Beauty acne cream

Benzene, a known carcinogen, was found not only in the acne products themselves but also in the air around incubated products, suggesting a potential inhalation risk. Valisure has filed a petition with the U.S. Food and Drug Administration (FDA) urging product recalls, investigations, and revised industry guidance. The situation is substantially different from previous cases where benzene impurities came from contaminated ingredients. Here, benzene originates directly from the benzoyl peroxide itself, forming at unacceptably high levels.

Consumers are advised to stay informed as regulatory responses unfold. The FDA’s reaction to Valisure’s petition remains pending. Companies implicated in this issue, including Estee Lauder, have yet to respond to media inquiries.

As we await further developments, it’s crucial to prioritize safety and informed choices when it comes to skincare products. 









Comments